Regardless the source of Sars-CoV-2, a worldwide public conversation regarding Gain of Function research and the Biological Weapons Convention needs to take place.
We assume this is not a bio attack. We assume the means of transmission is human sputum; without considering other possible vectors.
“On Dec 19, 2017, the US National Institutes of Health (NIH) announced that they would resume funding gain-of-function experiments involving influenza, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus.” https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30006-9/fulltext
It is highly probable there was a specific research project(s) that initiated the resumption of US funding. It is probable that research organizations closely and accurately record the identification of all persons participating in research; even those not credited in published documentation.
There is nothing that would have prevented Sars-CoV-2 from acquiring the S-2 cleavage site during US sponsored research. There is nothing that would have prevented the Sars-CoV-2 from acquiring that specific Gain of Function in the labs of Israel, Russia, China, or any number of other countries.
https://www.google.com/search?q=S-2+cleavage+site&oq=S-2+cleavage+site&aqs=chrome..69i57.5327j0j7&sourceid=chrome&ie=UTF-8
The probability is low that a collective nation state acted in this matter. It is possible that a small rogue element within nation state organization acted in this matter. It is possible person(s) unassociated to any nation state organization acted in this matter. It is probable that both nation state and rogue power have the capability to perform this type of bio-attack.
S-2 cleavage gain of function was a direction of active research prior to the pandemic. This makes the probability that S-2 cleavage gain of function in SARS-Cov-2 was naturally acquired quite low.
Comments rated to be "almost" Good Answers: